Abstract
Invasive lobular carcinoma (ILC) is the second most commonly diagnosed histological subtype of breast cancer, comprising up to 15% of all cases. Considerable data suggest there are fundamental clinical and biological differences between ILC and the more commonly diagnosed invasive carcinoma no special type. We sought to characterise clinical, pathological and biological parameters that could predict prognosis in ILC that would aid in the understanding of tumour subtype and in the management of patients diagnosed with this subtype of disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
